ATE478943T1 - Wachstumsfaktormutanten mit verbesserter biologischer aktivität - Google Patents

Wachstumsfaktormutanten mit verbesserter biologischer aktivität

Info

Publication number
ATE478943T1
ATE478943T1 AT06723209T AT06723209T ATE478943T1 AT E478943 T1 ATE478943 T1 AT E478943T1 AT 06723209 T AT06723209 T AT 06723209T AT 06723209 T AT06723209 T AT 06723209T AT E478943 T1 ATE478943 T1 AT E478943T1
Authority
AT
Austria
Prior art keywords
growth factor
biological activity
improved biological
factor mutants
mutants
Prior art date
Application number
AT06723209T
Other languages
English (en)
Inventor
Stefan Mundlos
Petra Knaus
Jens Pohl
Michael Kruse
Frank Ploeger
Original Assignee
Bioph Biotech Entw Pharm Gmbh
Charite Universitaetsmedizin
Univ Berlin Freie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioph Biotech Entw Pharm Gmbh, Charite Universitaetsmedizin, Univ Berlin Freie filed Critical Bioph Biotech Entw Pharm Gmbh
Application granted granted Critical
Publication of ATE478943T1 publication Critical patent/ATE478943T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06723209T 2005-03-04 2006-03-03 Wachstumsfaktormutanten mit verbesserter biologischer aktivität ATE478943T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05004840A EP1698691A1 (de) 2005-03-04 2005-03-04 Mutanten von Wachstumsfaktoren mit verbesserter biologischer Eigenschaft
PCT/EP2006/001966 WO2006094722A2 (en) 2005-03-04 2006-03-03 Growth factor mutants with improved biological activity

Publications (1)

Publication Number Publication Date
ATE478943T1 true ATE478943T1 (de) 2010-09-15

Family

ID=35431619

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06723209T ATE478943T1 (de) 2005-03-04 2006-03-03 Wachstumsfaktormutanten mit verbesserter biologischer aktivität

Country Status (10)

Country Link
US (1) US9012401B2 (de)
EP (2) EP1698691A1 (de)
JP (1) JP2008538073A (de)
AT (1) ATE478943T1 (de)
AU (1) AU2006222283B2 (de)
CA (1) CA2600951A1 (de)
DE (1) DE602006016406D1 (de)
DK (1) DK1856249T3 (de)
ES (1) ES2348404T3 (de)
WO (1) WO2006094722A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1915986A1 (de) * 2006-10-23 2008-04-30 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Wachstumsfaktorhaltige Lipidformulierungen
EP2019117A1 (de) * 2007-07-27 2009-01-28 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Optimiertes Reinigungsverfahren für rekombinantes Wachstumsfaktorprotein
JP5837930B2 (ja) * 2010-07-30 2015-12-24 ビオファーム・ゲゼルシャフト・ツァ・ビオテヒノロジッシェン・エントヴィックルング・フォン・ファルマカ・エムベーハー 創傷の治癒を加速する医薬送達装置及び増殖因子製剤
EP2537538A1 (de) * 2011-06-22 2012-12-26 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH Bioresorbierbarer Wundverband
EP2602264A1 (de) * 2011-12-05 2013-06-12 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH GDF-5-Mutant zur Induzierung der Knorpelbildung
EP4599842A1 (de) * 2024-02-09 2025-08-13 Association Institut de Myologie Pegyliertes gdf5-protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110589A0 (en) 1993-08-10 1994-11-11 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF- beta family
CA2344277A1 (en) 1998-09-22 2000-03-30 University Of Maryland, Baltimore Cystine knot growth factor mutants
US6677432B1 (en) * 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins
US20110039773A1 (en) * 2007-12-21 2011-02-17 Stryker Biotech BMP Mutants with Decreased Susceptibility to Noggin

Also Published As

Publication number Publication date
DE602006016406D1 (de) 2010-10-07
JP2008538073A (ja) 2008-10-09
WO2006094722A2 (en) 2006-09-14
US9012401B2 (en) 2015-04-21
AU2006222283A1 (en) 2006-09-14
EP1856249B1 (de) 2010-08-25
ES2348404T3 (es) 2010-12-03
US20080260830A1 (en) 2008-10-23
CA2600951A1 (en) 2006-09-14
EP1698691A1 (de) 2006-09-06
WO2006094722A3 (en) 2007-02-01
AU2006222283B2 (en) 2011-06-09
DK1856249T3 (da) 2010-11-15
EP1856249A2 (de) 2007-11-21

Similar Documents

Publication Publication Date Title
EP1949631A4 (de) Multiplex-verfahren für ofdma
CA112249S (en) Pet house carrier
CY1112877T1 (el) Μεταλλαγματα αυξητικου παραγoντα υψηλης δραστικοτητας
HRP20080098T3 (en) Cutting element structure for garden trimmer
EA200702529A1 (ru) Фунгицидная комбинация биологически активных веществ
FR2917944B1 (fr) Pretailleuse de cultures palissees, en particulier de la vigne.
DK2314668T3 (da) Gen-inaktiverede mutanter med ændret proteinproduktion
ATE516023T1 (de) Vielseitige hoch konzentrierte zubereitung mit metaflumizon zur kontrolle von ektoparasiten
ATE478943T1 (de) Wachstumsfaktormutanten mit verbesserter biologischer aktivität
ES1061127Y (es) Jaula para el cultivo acuatico de moluscos.
ATE507222T1 (de) 1,1-dioxo-thiomorpholinyl-indolyl-methanon- derivate zur verwendung als h3-modulatoren
DE602005005032D1 (de) Lagerstabiles product mit lebenden mikroorganismen
ITRM20050235A1 (it) Tracciante alimentare naturale.
PL1865766T3 (pl) Gniazda dla niosek
ITRM20050556A1 (it) Struttura di ancoraggio per organismi vegetali.
ATE458507T1 (de) Implantat mit mehrfachbeschichtung
ITVI20050139A1 (it) Apparecchio di illuminazione ad ingombro contenuto
DE602004019824D1 (de) Modifizierte ethylendiamin-n,n'-dibernsteinsäure:ethylendiamin-lyase
ATE463499T1 (de) Silizium-harnstoff-azolide, ihre herstellung und verwendung
NL1023158A1 (nl) Plantpot met verdiepte bodem.
EP1896003A4 (de) Parenterales selenomethionin zur herstellung von selenreichen nahrungsmitteln
EP1940415A4 (de) 19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3
AU306689S (en) Corkscrew
ATE478948T1 (de) Nichtmenschliches tier mit adam11-gen- unterbrechung
ES1060475Y (es) "cubeta desmontable para el riego de macetas".

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties